Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 4/20 | 0.74 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.74 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.74 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.74 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.74 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.74 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.74 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.74 |
| ▸ | ABCG2 | Q9UNQ0 | 8/20 | 0.73 |
| ▸ | ABCB1 | P08183 | 6/20 | 0.73 |
| ▸ | ABCC1 | P33527 | 2/20 | 0.73 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.73 |
| ▸ | TUBB4A | P04350 | 2/20 | 0.70 |
| ▸ | TUBB | P07437 | 2/20 | 0.70 |
| ▸ | TUBA3C | P0DPH7 | 2/20 | 0.70 |
| ▸ | TUBA1B | P68363 | 2/20 | 0.70 |
| ▸ | TUBA4A | P68366 | 2/20 | 0.70 |
| ▸ | TUBB4B | P68371 | 2/20 | 0.70 |
| ▸ | TUBB3 | Q13509 | 2/20 | 0.70 |
| ▸ | TUBB2A | Q13885 | 2/20 | 0.70 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hexamethoxyflavone SCHEMBL30232628 | 1.00 | MEN1 (0.74) | MEN1KMT2AALDH1A1KDM4ECYP3A4 | |
| SCHEMBL19347141 | 0.89 | ABCG2 (0.72) | MEN1KMT2AALDH1A1KDM4ECYP3A4 | |
| SCHEMBL31287150 | 0.89 | ADORA3 (0.72) | MEN1KMT2AALDH1A1KDM4ECYP3A4 | |
| SCHEMBL16894654 | 0.89 | ADORA3 (0.72) | MEN1KMT2AALDH1A1KDM4ECYP3A4 | |
| Artemetin SCHEMBL29550082 | 0.88 | TUBB4A (0.84) | MEN1KMT2AALDH1A1KDM4ECYP3A4 | |
| SCHEMBL30082745 | 0.88 | MEN1 (0.84) | MEN1KMT2AALDH1A1KDM4ECYP3A4 | |
| SCHEMBL1764647 | 0.88 | TUBB4A (0.84) | MEN1KMT2AALDH1A1KDM4ECYP3A4 | |
| SCHEMBL1421395 | 0.88 | ABCG2 (0.68) | MEN1KMT2AALDH1A1KDM4ECYP3A4 | |
| Artemetin SCHEMBL2122576 | 0.88 | TUBB4A (0.84) | MEN1KMT2AALDH1A1KDM4ECYP3A4 | |
| Artemetin SCHEMBL29416756 | 0.88 | TUBB4A (0.84) | MEN1KMT2AALDH1A1KDM4ECYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 133 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119881142-A | Method for screening alpha-glucosidase inhibitor from dried orange peel and application | 北京同仁堂股份有限公司 | 2025-04-25 | — | — | CN | claimed |
| CN-118903051-A | Tea polyphenol and caffeine combined polymethoxy flavone preparation and preparation method thereof | 华中农业大学 | 2024-11-08 | — | — | CN | claimed |
| US-20240188613-A1 | SWEETENER COMPOSITIONS COMPRISING MOGROSIDES AND USES THEREOF | FIRMENICH INCORPORATED | 2024-06-13 | — | — | US | claimed |
| US-20240090547-A1 | SWEETENER COMPOSITIONS COMPRISING MOGROSIDES AND USES THEREOF | FIRMENICH INCORPORATED | 2024-03-21 | — | — | US | claimed |
| US-20240065302-A1 | SWEETENER COMPOSITIONS COMPRISING MOGROSIDES AND USES THEREOF | FIRMENICH INCORPORATED | 2024-02-29 | — | — | US | claimed |
| EP-4258897-A1 | SWEETENER COMPOSITIONS COMPRISING MOGROSIDES AND USES THEREOF | Firmenich Incorporated (US) | 2023-10-18 | — | — | EP | claimed |
| EP-4258896-A1 | SWEETENER COMPOSITIONS COMPRISING MOGROSIDES AND USES THEREOF | Firmenich Incorporated (US) | 2023-10-18 | — | — | EP | claimed |
| WO-2022155669-A1 | SWEETENER COMPOSITIONS COMPRISING MOGROSIDES AND USES THEREOF | FIRMENICH INCORPORATED (US) | 2022-07-21 | — | — | WO | claimed |
| WO-2022155667-A1 | SWEETENER COMPOSITIONS COMPRISING MOGROSIDES AND USES THEREOF | FIRMENICH INCORPORATED (US) | 2022-07-21 | — | — | WO | claimed |
| CN-109374762-B | Method for identifying citrus reticulata blanco and citrus reticulata blanco varieties based on metabonomics | 广州中医药大学第一附属医院 | 2021-10-08 | — | — | CN | claimed |
| CN-112691052-A | Pure natural high-stability polymethoxylated flavone nano-emulsion and preparation and application thereof | 杭州诺莘科技有限责任公司 | 2021-04-23 | — | — | CN | claimed |
| US-10682332-B2 | Method for treating melanoma | Huanggang normal university (CN) | 2020-06-16 | — | — | US | claimed |
| US-20190046498-A1 | METHOD FOR TREATING MELANOMA | HENAN UNIVERSITY (CN) | 2019-02-14 | — | — | US | claimed |
| WO-2018125950-A1 | A COMBINATION THERAPY FOR TREATING CANCER | Huanggang normal university (CN) | 2018-07-05 | — | — | WO | claimed |
| US-9763910-B1 | Combination therapy for treating cancer | Huanggang normal university (CN) | 2017-09-19 | — | — | US | claimed |
| US-9669003-B2 | Use of flavone and flavanone derivatives in preparation of sedative and hypnotic drugs | JIN YONGRI (CN) | 2017-06-06 | — | — | US | claimed |
| US-20150196529-A1 | USE OF FLAVONE AND FLAVANONE DERIVATIVES IN PREPARATION OF SEDATIVE AND HYPNOTIC DRUGS | JIN YONGRI (CN) | 2015-07-16 | — | — | US | claimed |
| EP-2494874-B1 | Control of flavor characteristics of fruit juice | TROPICANA PROD INC (US) | 2013-12-11 | — | — | EP | claimed |
| EP-2494874-A1 | Control of flavor characteristics of fruit juice | TROPICANA PRODUCTS, INC. (US) | 2012-09-05 | — | — | EP | claimed |
| US-20260115294-A1 | DERIVATIVES OF 5-HYDROXYLATED POLYMETHOXYFLAVONES WITH ENHANCED BIOAVAILABILITY FOR ORAL DELIVERY AND COMPOSITIONS THEREOF | DEEPSENSE BIOTECHNOLOGIES INC (US) | 2026-04-30 | — | — | US | disclosed |
| US-20260014082-A1 | SOLID COMPOSITION CONTAINING AMORPHOUS, POORLY WATER-SOLUBLE MATERIAL, AND METHOD FOR PRODUCING SAME | SAN EI GEN FFI INC (JP) | 2026-01-15 | — | — | US | disclosed |
| US-12453701-B2 | Solid composition containing amorphous, poorly water-soluble material, and method for producing same | SAN-EI GEN F.F.I., INC. (JP) | 2025-10-28 | — | — | US | disclosed |
| EP-4580594-A1 | ANTIOXIDANT COMPOSITION COMPRISING 5-DEOXYFLAVONOIDS | AnalytiCon Discovery - Zweigniederlassung der BRAIN Biotech AG (DE) | 2025-07-09 | — | — | EP | disclosed |
| US-20250145581-A1 | PURIFICATION PROCESS FOR POLYMETHOXYLATED FLAVONOIDS AND COMPOSITIONS OBTAINED THEREFROM | FIRMENICH SA (CH) | 2025-05-08 | — | — | US | disclosed |
| CN-119881142-A | Method for screening alpha-glucosidase inhibitor from dried orange peel and application | 北京同仁堂股份有限公司 | 2025-04-25 | — | — | CN | disclosed |
| CN-118903051-A | Tea polyphenol and caffeine combined polymethoxy flavone preparation and preparation method thereof | 华中农业大学 | 2024-11-08 | — | — | CN | disclosed |
| CN-118785815-A | Method for purifying polymethoxy flavonoids and composition obtained by the method | 弗门尼舍有限公司 | 2024-10-15 | — | — | CN | disclosed |
| EP-4440334-A1 | PURIFICATION PROCESS FOR POLYMETHOXYLATED FLAVONOIDS AND COMPOSITIONS OBTAINED THEREFROM | Firmenich SA (CH) | 2024-10-09 | — | — | EP | disclosed |
| US-20240216296-A1 | POLYPHENOL COMPOSITIONS HAVING IMPROVED BIOAVAILABILITY | EPICEUTICAL LABS LLC | 2024-07-04 | — | — | US | disclosed |
| EP-4391834-A1 | METHODS FOR IMPROVING GUT MICROBIOTA DIVERSITY | Société des Produits Nestlé S.A. (CH) | 2024-07-03 | — | — | EP | disclosed |
| CN-115315194-B | Hydroxy-and methoxy-substituted flavones and use thereof | 弗门尼舍有限公司 | 2024-06-21 | — | — | CN | disclosed |
| US-20240188613-A1 | SWEETENER COMPOSITIONS COMPRISING MOGROSIDES AND USES THEREOF | FIRMENICH INCORPORATED | 2024-06-13 | — | — | US | disclosed |
| US-20240114939-A1 | HYDROXY- AND METHOXY-SUBSTITUTED FLAVONES AND THEIR USE | FIRMENICH SA (CH) | 2024-04-11 | — | — | US | disclosed |
| US-20240101791-A1 | POLYMER COMPOSITES | WARNER BABCOCK INSTITUTE FOR GREEN CHEMISTRY, LLC (US) | 2024-03-28 | — | — | US | disclosed |
| WO-2024059282-A1 | IMPROVED POLYMER COMPOSITES | WARNER BABCOCK INSTITUTE FOR GREEN CHEMISTRY, LLC (US) | 2024-03-21 | — | — | WO | disclosed |
| US-20240090547-A1 | SWEETENER COMPOSITIONS COMPRISING MOGROSIDES AND USES THEREOF | FIRMENICH INCORPORATED | 2024-03-21 | — | — | US | disclosed |
| WO-2024046834-A1 | ANTIOXIDANT COMPOSITION COMPRISING 5-DEOXYFLAVONOIDS | ANALYTICON DISCOVERY GMBH (DE) | 2024-03-07 | — | — | WO | disclosed |
| EP-4331564-A1 | ANTIOXIDANT COMPOSITION COMPRISING 5-DEOXYFLAVONOIDS | Analyticon Discovery GmbH (DE) | 2024-03-06 | — | — | EP | disclosed |
| US-20240065302-A1 | SWEETENER COMPOSITIONS COMPRISING MOGROSIDES AND USES THEREOF | FIRMENICH INCORPORATED | 2024-02-29 | — | — | US | disclosed |
| CN-117098460-A | Sweetener composition comprising mogrosides and uses thereof | 弗门尼舍公司 | 2023-11-21 | — | — | CN | disclosed |
| CN-116997263-A | Sweetener compositions comprising siamenoside I and uses thereof | 弗门尼舍公司 | 2023-11-03 | — | — | CN | disclosed |
| US-11801209-B2 | Cooling and flavor boosting compositions | FIRMENICH SA (CH) | 2023-10-31 | — | — | US | disclosed |
| CN-116963609-A | Sweetener composition comprising mogrosides and uses thereof | 弗门尼舍公司 | 2023-10-27 | — | — | CN | disclosed |
| EP-4258897-A1 | SWEETENER COMPOSITIONS COMPRISING MOGROSIDES AND USES THEREOF | Firmenich Incorporated (US) | 2023-10-18 | — | — | EP | disclosed |
| EP-4258899-A1 | HYDROXY- AND METHOXY-SUBSTITUTED FLAVONES AND THEIR USE | Firmenich SA (CH) | 2023-10-18 | — | — | EP | disclosed |
| EP-4258896-A1 | SWEETENER COMPOSITIONS COMPRISING MOGROSIDES AND USES THEREOF | Firmenich Incorporated (US) | 2023-10-18 | — | — | EP | disclosed |
| CN-114984103-B | Orange peel extract and preparation method and application thereof | 赣南师范大学 | 2023-10-03 | — | — | CN | disclosed |
| WO-2023165764-A1 | PURIFICATION PROCESS FOR POLYMETHOXYLATED FLAVONOIDS AND COMPOSITIONS OBTAINED THEREFROM | FIRMENICH SA (CH) | 2023-09-07 | — | — | WO | disclosed |
| WO-2023165764-A1 | PURIFICATION PROCESS FOR POLYMETHOXYLATED FLAVONOIDS AND COMPOSITIONS OBTAINED THEREFROM | FIRMENICH SA (CH) | 2023-09-07 | — | — | WO | disclosed |
| US-20230255989-A1 | GLYCAN COMPOSITIONS AND USES THEREOF | DSM NUTRITIONAL PRODUCTS LLC (US) | 2023-08-17 | — | — | US | disclosed |
| WO-2023025722-A1 | METHODS FOR IMPROVING GUT MICROBIOTA DIVERSITY | Société des Produits Nestlé S.A. (CH) | 2023-03-02 | — | — | WO | disclosed |
| US-20230041523-A1 | COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE AND METABOLIC DISORDERS | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED | 2023-02-09 | — | — | US | disclosed |
| US-20230040337-A1 | SOLID COMPOSITION CONTAINING AMORPHOUS, POORLY WATER-SOLUBLE MATERIAL, AND METHOD FOR PRODUCING SAME | SAN-EI GEN F.F.I., INC. (JP) | 2023-02-09 | — | — | US | disclosed |
| US-20230041523-A1 | COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE AND METABOLIC DISORDERS | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED | 2023-02-09 | — | — | US | disclosed |
| CN-115315194-A | Hydroxy-and methoxy-substituted flavones and their use | 弗门尼舍有限公司 | 2022-11-08 | — | — | CN | disclosed |
| WO-2022189155-A1 | HYDROXY- AND METHOXY-SUBSTITUTED FLAVONES AND THEIR USE | FIRMENICH SA (CH) | 2022-09-15 | — | — | WO | disclosed |
| CN-114984103-A | Orange peel extract and preparation method and application thereof | 赣南师范大学 | 2022-09-02 | — | — | CN | disclosed |
| CN-112691052-B | Pure natural high-stability polymethoxylated flavone nano-emulsion and preparation and application thereof | 杭州诺莘科技有限责任公司 | 2022-08-09 | — | — | CN | disclosed |
| US-20220236254-A1 | BITTER TASTE RECEPTOR BLOCKERS AND METHODS OF THEIR IDENTIFICATION | FIRMENICH INCORPORATED | 2022-07-28 | — | — | US | disclosed |
| WO-2022155669-A1 | SWEETENER COMPOSITIONS COMPRISING MOGROSIDES AND USES THEREOF | FIRMENICH INCORPORATED (US) | 2022-07-21 | — | — | WO | disclosed |
| WO-2022155667-A1 | SWEETENER COMPOSITIONS COMPRISING MOGROSIDES AND USES THEREOF | FIRMENICH INCORPORATED (US) | 2022-07-21 | — | — | WO | disclosed |
| EP-4023246-A1 | SOLID COMPOSITION CONTAINING AMORPHOUS, POORLY WATER-SOLUBLE MATERIAL, AND METHOD FOR PRODUCING SAME | San-Ei Gen F.F.I., INC. (JP) | 2022-07-06 | — | — | EP | disclosed |
| US-20220160802-A1 | METHODS AND COMPOSITIONS FOR PROMOTING HEALTH IN A SUBJECT | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2022-05-26 | — | — | US | disclosed |
| CN-114466641-A | Solid compositions containing non-crystalline poorly water soluble materials and methods of producing the same | 三荣源有限公司 | 2022-05-10 | — | — | CN | disclosed |
| EP-3987288-A1 | BITTER TASTE RECEPTOR BLOCKERS AND METHODS OF THEIR IDENTIFICATION | Firmenich Incorporated (US) | 2022-04-27 | — | — | EP | disclosed |
| US-20220110351-A1 | POLYMETHOXYFLAVONES AND THEIR USE AS MOUTHFEEL ENHANCERS AND BITTERNESS MASKERS | FIRMENICH SA (CH) | 2022-04-14 | — | — | US | disclosed |
| US-20220110351-A1 | POLYMETHOXYFLAVONES AND THEIR USE AS MOUTHFEEL ENHANCERS AND BITTERNESS MASKERS | FIRMENICH SA (CH) | 2022-04-14 | — | — | US | disclosed |
| US-11229660-B2 | Glycan therapeutics and method of treating conditions associated with TMAO | KALEIDO BIOSCIENCES, INC. (US) | 2022-01-25 | — | — | US | disclosed |
| CN-112601461-B | Polymethoxylated flavones as sweetness enhancers | 弗门尼舍有限公司 | 2021-10-22 | — | — | CN | disclosed |
| CN-109374762-B | Method for identifying citrus reticulata blanco and citrus reticulata blanco varieties based on metabonomics | 广州中医药大学第一附属医院 | 2021-10-08 | — | — | CN | disclosed |
| EP-3862002-A1 | GLYCAN THERAPEUTICS AND RELATED METHODS THEREOF | Kaleido Biosciences, Inc. (US) | 2021-08-11 | — | — | EP | disclosed |
| CN-113015437-A | Polymethoxyflavone and its use as taste enhancer and bitterness masking agent | 弗门尼舍有限公司 | 2021-06-22 | — | — | CN | disclosed |
| CN-113015437-A | Polymethoxyflavone and its use as taste enhancer and bitterness masking agent | 弗门尼舍有限公司 | 2021-06-22 | — | — | CN | disclosed |
| EP-3829321-A1 | POLYMETHOXYFLAVONES AND THEIR USE AS MOUTHFEEL ENHANCERS AND BITTERNESS MASKERS | Firmenich SA (CH) | 2021-06-09 | — | — | EP | disclosed |
| EP-3829321-A1 | POLYMETHOXYFLAVONES AND THEIR USE AS MOUTHFEEL ENHANCERS AND BITTERNESS MASKERS | Firmenich SA (CH) | 2021-06-09 | — | — | EP | disclosed |
| US-20210161188-A1 | POLYMETHOXYFLAVONES AS SWEETNESS ENHANCERS | FIRMENICH SA (CH) | 2021-06-03 | — | — | US | disclosed |
| US-20210161188-A1 | POLYMETHOXYFLAVONES AS SWEETNESS ENHANCERS | FIRMENICH SA (CH) | 2021-06-03 | — | — | US | disclosed |
| US-20210137956-A1 | GLYCAN COMPOSITIONS AND USES THEREOF | HERCULES CAPITAL, INC. | 2021-05-13 | — | — | US | disclosed |
| CN-112691052-A | Pure natural high-stability polymethoxylated flavone nano-emulsion and preparation and application thereof | 杭州诺莘科技有限责任公司 | 2021-04-23 | — | — | CN | disclosed |
| US-20210113596-A1 | GLYCAN THERAPEUTICS AND RELATED METHODS THEREOF | KALEIDO BIOSCIENCES, INC. (US) | 2021-04-22 | — | — | US | disclosed |
| CN-112601461-A | Polymethoxylated flavones as sweetness enhancers | 弗门尼舍有限公司 | 2021-04-02 | — | — | CN | disclosed |
| EP-3758509-A1 | POLYMETHOXYFLAVONES AS SWEETNESS ENHANCERS | Firmenich SA (CH) | 2021-01-06 | — | — | EP | disclosed |
| US-10881676-B2 | Glycan therapeutics and related methods thereof | KALEIDO BIOSCIENCES, INC. (US) | 2021-01-05 | — | — | US | disclosed |
| EP-3354282-B1 | GLYCAN THERAPEUTICS AND RELATED METHODS THEREOF | KALEIDO BIOSCIENCES INC (US) | 2020-12-30 | — | — | EP | disclosed |
| WO-2020232255-A1 | COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE AND METABOLIC DISORDERS | THE SCRIPPS RESEARCH INSTITUTE (US) | 2020-11-19 | — | — | WO | disclosed |
| US-20200306156-A1 | COOLING AND FLAVOR BOOSTING COMPOSITIONS | FIRMENICH SA (CH) | 2020-10-01 | — | — | US | disclosed |
| US-20200255872-A1 | Isothiocyanate containing Brassicaceae Products and Method of Preparation Thereof | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2020-08-13 | — | — | US | disclosed |
| US-10702542-B2 | Glycan therapeutics and related methods thereof | KALEIDO BIOSCIENCES, INC. (US) | 2020-07-07 | — | — | US | disclosed |
| US-10682332-B2 | Method for treating melanoma | Huanggang normal university (CN) | 2020-06-16 | — | — | US | disclosed |
| WO-2020074436-A1 | POLYMETHOXYFLAVONES AND THEIR USE AS MOUTHFEEL ENHANCERS AND BITTERNESS MASKERS | FIRMENICH SA (CH) | 2020-04-16 | — | — | WO | disclosed |
| US-20200093845-A1 | GLYCAN THERAPEUTICS AND RELATED METHODS THEREOF | HERCULES CAPITAL, INC. | 2020-03-26 | — | — | US | disclosed |
| US-20200093851-A1 | GLYCAN THERAPEUTICS AND RELATED METHODS THEREOF | HERCULES CAPITAL, INC. | 2020-03-26 | — | — | US | disclosed |
| WO-2020025639-A1 | POLYMETHOXYFLAVONES AS SWEETNESS ENHANCERS | FIRMENICH SA (CH) | 2020-02-06 | — | — | WO | disclosed |
| WO-2020025639-A1 | POLYMETHOXYFLAVONES AS SWEETNESS ENHANCERS | FIRMENICH SA (CH) | 2020-02-06 | — | — | WO | disclosed |
| US-10314853-B2 | Glycan therapeutics and related methods thereof | KALEIDO BIOSCIENCES, INC. (US) | 2019-06-11 | — | — | US | disclosed |
| US-20190046498-A1 | METHOD FOR TREATING MELANOMA | HENAN UNIVERSITY (CN) | 2019-02-14 | — | — | US | disclosed |
| US-20180235987-A1 | GLYCAN COMPOSITIONS AND USES THEREOF | HERCULES CAPITAL, INC. | 2018-08-23 | — | — | US | disclosed |
| EP-3354282-A1 | GLYCAN THERAPEUTICS AND RELATED METHODS THEREOF | Kaleido Biosciences, Inc. (US) | 2018-08-01 | — | — | EP | disclosed |
| WO-2018125950-A1 | A COMBINATION THERAPY FOR TREATING CANCER | Huanggang normal university (CN) | 2018-07-05 | — | — | WO | disclosed |
| EP-3334437-A1 | GLYCAN COMPOSITIONS AND USES THEREOF | Kaleido Biosciences, Inc. (US) | 2018-06-20 | — | — | EP | disclosed |
| US-20180147222-A1 | GLYCAN THERAPEUTICS AND RELATED METHODS THEREOF | HERCULES CAPITAL, INC. | 2018-05-31 | — | — | US | disclosed |
| US-9901595-B2 | Glycan therapeutics for reducing blood ammonia | KALEIDO BIOSCIENCES, INC. (US) | 2018-02-27 | — | — | US | disclosed |
| US-20180042899-A1 | Method of Treating Transplant Rejection and Autoimmune Diseases | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2018-02-15 | — | — | US | disclosed |
| US-9763910-B1 | Combination therapy for treating cancer | Huanggang normal university (CN) | 2017-09-19 | — | — | US | disclosed |
| US-9757403-B2 | Glycan therapeutics and related methods thereof | KALEIDO BIOSCIENCES, INC. (US) | 2017-09-12 | — | — | US | disclosed |
| US-20170246201-A1 | GLYCAN THERAPEUTICS AND RELATED METHODS THEREOF | HERCULES CAPITAL, INC. | 2017-08-31 | — | — | US | disclosed |
| US-9669003-B2 | Use of flavone and flavanone derivatives in preparation of sedative and hypnotic drugs | JIN YONGRI (CN) | 2017-06-06 | — | — | US | disclosed |
| US-20170151269-A1 | GLYCAN THERAPEUTICS AND RELATED METHODS THEREOF | HERCULES CAPITAL, INC. | 2017-06-01 | — | — | US | disclosed |
| US-20170151268-A1 | GLYCAN THERAPEUTICS AND RELATED METHODS THEREOF | HERCULES CAPITAL, INC. | 2017-06-01 | — | — | US | disclosed |
| WO-2017035412-A1 | GLYCAN COMPOSITIONS AND USES THEREOF | KALEIDO BIOSCIENCES, INC. (US) | 2017-03-02 | — | — | WO | disclosed |
| US-9492473-B2 | Glycan therapeutics and related methods thereof | KALEIDO BIOSCIENCES, INC. (US) | 2016-11-15 | — | — | US | disclosed |
| EP-3071235-A1 | GLYCAN THERAPEUTICS AND RELATED METHODS THEREOF | Kaleido Biosciences, Inc. (US) | 2016-09-28 | — | — | EP | disclosed |
| WO-2016122889-A1 | GLYCAN THERAPEUTICS AND RELATED METHODS THEREOF | KALEIDO BIOSCIENCES, INC. (US) | 2016-08-04 | — | — | WO | disclosed |
| US-20160213702-A1 | GLYCAN THERAPEUTICS AND RELATED METHODS THEREOF | KALEIDO BIOSCIENCES, INC. (US) | 2016-07-28 | — | — | US | disclosed |
| US-20150196529-A1 | USE OF FLAVONE AND FLAVANONE DERIVATIVES IN PREPARATION OF SEDATIVE AND HYPNOTIC DRUGS | JIN YONGRI (CN) | 2015-07-16 | — | — | US | disclosed |
| US-8980352-B2 | Control of flavor characteristics of and indicator of freshness in fruit juice | TROPICANA PRODUCTS, INC. (US) | 2015-03-17 | — | — | US | disclosed |
| US-20140050694-A1 | Method of Treating Transplant Rejection and Autoimmune Diseases | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2014-02-20 | — | — | US | disclosed |
| EP-2494874-B1 | Control of flavor characteristics of fruit juice | TROPICANA PROD INC (US) | 2013-12-11 | — | — | EP | disclosed |
| EP-2217098-B1 | CONTROL OF FLAVOR CHARACTERISTICS OF AND INDICATOR OF FRESHNESS IN FRUIT JUICE | TROPICANA PROD INC (US) | 2013-08-07 | — | — | EP | disclosed |
| US-8435586-B2 | Use of alkoxylated flavones to intensify the sensory impression of alcohol | SYMRISE AG (DE) | 2013-05-07 | — | — | US | disclosed |
| US-8367121-B2 | Nutraceutical agent for attenuating the neurodegenerative process associated with Parkinson's disease | FLORIDA A & M UNIVERSITY (US) | 2013-02-05 | — | — | US | disclosed |
| EP-2494874-A1 | Control of flavor characteristics of fruit juice | TROPICANA PRODUCTS, INC. (US) | 2012-09-05 | — | — | EP | disclosed |
| EP-2274991-B1 | Control of flavor characteristics of and indicator of freshness in fruit juice | TROPICANA PROD INC (US) | 2012-05-30 | — | — | EP | disclosed |
| EP-2078462-B1 | Application of alkoxylised flavones for reinforcing the taste impression of alcohol | SYMRISE AG (DE) | 2011-10-12 | — | — | EP | disclosed |
| EP-2274991-A2 | Control of flavor characteristics of and indicator of freshness in fruit juice | TROPICANA PRODUCTS, INC. (US) | 2011-01-19 | — | — | EP | disclosed |
| US-20100150895-A1 | Nutraceutical agent for attenuating the Neurodegenerative process associated with Parkinson's disease | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2010-06-17 | — | — | US | disclosed |
| US-20090269772-A1 | SYSTEMS AND METHODS FOR IDENTIFYING COMBINATIONS OF COMPOUNDS OF THERAPEUTIC INTEREST | THERASIS, INC. | 2009-10-29 | — | — | US | disclosed |
| EP-2078462-A1 | Application of alkoxylised flavones for reinforcing the taste impression of alcohol | Symrise GmbH & Co. KG (DE) | 2009-07-15 | — | — | EP | disclosed |
| US-20090175995-A1 | CONTROL OF FLAVOR CHARACTERISTICS OF AND INDICATOR OF FRESHNESS IN FRUIT JUICE | TROPICANA PRODUCTS, INC. (US) | 2009-07-09 | — | — | US | disclosed |
| US-20090162510-A1 | USE OF ALKOXYLATED FLAVONES TO INTENSIFY THE SENSORY IMPRESSION OF ALCOHOL | SYMRISE GMBH & CO. KG (DE) | 2009-06-25 | — | — | US | disclosed |
| US-20080292607-A1 | Nutraceutical agent for attenuating the neurodegenerative process associated with Parkinson's disease | MAZZIO ELIZABETH | 2008-11-27 | — | — | US | disclosed |
| WO-2007083263-A1 | PROCESS TO PREPARE FLAVONES | FIRMENICH SA (CH) | 2007-07-26 | — | — | WO | disclosed |
| US-20070116779-A1 | Comprehensive nutraceutical agent for treatment/ prevention of Parkinson's disease | MAZZIO ELIZABETH | 2007-05-24 | — | — | US | disclosed |
| US-20070116779-A1 | Comprehensive nutraceutical agent for treatment/ prevention of Parkinson's disease | MAZZIO ELIZABETH | 2007-05-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260014082-A1 | SOLID COMPOSITION CONTAINING AMORPHOUS, POORLY WATER-SOLUBLE MATERIAL, AND METHOD FOR PRODUCING SAME | GC, CSNK1D, CCND3 | MEN1 2708/4885KMT2A 881/4885ALDH1A1 2608/4885 |
| US-20210161188-A1 | POLYMETHOXYFLAVONES AS SWEETNESS ENHANCERS | GPR119, MGAM, HKDC1 | MEN1 821/4885KMT2A 1124/4885ALDH1A1 4716/4885 |
| US-20230041523-A1 | COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE AND METABOLIC DISORDERS | NLN, GLS, PRNP | MEN1 3772/4885KMT2A 3429/4885ALDH1A1 495/4885 |
| US-20200306156-A1 | COOLING AND FLAVOR BOOSTING COMPOSITIONS | TAS2R20, TAS2R10, TAS2R40 | MEN1 2456/4885KMT2A 3340/4885ALDH1A1 1722/4885 |
| US-11801209-B2 | Cooling and flavor boosting compositions | TAS2R20, TAS2R10, TAS2R40 | MEN1 2456/4885KMT2A 3340/4885ALDH1A1 1722/4885 |
| US-20260115294-A1 | DERIVATIVES OF 5-HYDROXYLATED POLYMETHOXYFLAVONES WITH ENHANCED BIOAVAILABILITY FOR ORAL DELIVERY AND COMPOSITIONS THEREOF | PLIN3, PNLIP, FABP2 | MEN1 3906/4885KMT2A 4701/4885ALDH1A1 2873/4885 |
| US-20150196529-A1 | USE OF FLAVONE AND FLAVANONE DERIVATIVES IN PREPARATION OF SEDATIVE AND HYPNOTIC DRUGS | CYP2D6, GATAD2A, CYP3A43 | MEN1 3778/4885KMT2A 499/4885ALDH1A1 668/4885 |
| US-20250145581-A1 | PURIFICATION PROCESS FOR POLYMETHOXYLATED FLAVONOIDS AND COMPOSITIONS OBTAINED THEREFROM | TAS2R40, TAS2R60, TAS2R45 | MEN1 604/4885KMT2A 4411/4885ALDH1A1 4668/4885 |
| US-20240216296-A1 | POLYPHENOL COMPOSITIONS HAVING IMPROVED BIOAVAILABILITY | FABP2, HDLBP, FABP1 | MEN1 4422/4885KMT2A 3055/4885ALDH1A1 3482/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.